India to Serbia: Meloxicam Export Trade Route

The India to Serbia Meloxicam corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $6.0M USD. The route is dominated by UNICHEM LABORATORIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's meloxicam manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $6.0M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 29.9%, placing it at rank #18 among India's top meloxicam export destinations globally.

On the import side, key buyers of Indian meloxicam in Serbia include PHARMAS D.O.O.. PHARMAS D.O.O. is the single largest importer with 1 shipments valued at $6.0M USD.

India's meloxicam exports to Serbia are driven primarily by a handful of large-scale manufacturers. UNICHEM LABORATORIES LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Serbia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — UNICHEM LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $6.0M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

On the buying side, PHARMAS D.O.O. is the largest importer with 1 shipments worth $6.0M USD — representing 100% of all meloxicam imports from India on this route.